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The  generation  of a  humoral  immune  response  depends  on  the  interaction 
between  B  lymphocytes,  which  synthesize  immunoglobulin,  and  other  cells, 
including  T  lymphocytes,  which  function  to  regulate  the  B  cell  response.  Al- 
though an organism can respond to a  large set of diverse antigens,  individual T 
and B  cells synthesize receptors that can recognize only a  few related antigenic 
determinants.  B cells bind antigen through cell-surface immunoglobulin, a  mol- 
ecule composed of two identical  heavy (H) ~ and  two identical  light (either  X or 
~) polypeptide chains.  During differentiation, individual  B cells undergo a  series 
of DNA rearrangements, becoming committed to the synthesis of immunoglob- 
ulin of a  single specificity.  The light chain  variable region  in both the  ~  and  K 
gene families is encoded  by two distinct  gene  segments,  V~ or V~ and Jx or JK, 
which  become joined  by a  DNA  rearrangement  to  produce a  transcriptionally 
active light chain gene (1). Similarly, the heavy chain variable region is composed 
of three  separate gene segments, VH,  D, and JH, which  become joined  to form 
the expressed heavy chain gene (2). 
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T  cells also exhibit a  high  degree of antigen  specificity, but  the molecular 
nature of the T cell receptor for antigen is not well characterized. Previous work 
has shown that the antigen receptor on T  cells is not a  conventional immuno- 
globulin; many functional murine T  cells do not transcribe the CH, Ca, C,, JH, Jx, 
or J, gene segments that are required for encoding a complete immunoglobulin 
molecule (3). However, serological studies have revealed that T  cells involved in 
the responses to synthetic polypeptides (4-6), carbohydrate residues (7), alloan- 
tigens  (8),  haptens  (9-11),  and  protein  antigens  (12)  express  cross-reactive 
idiotypic determinants characteristic of immunoglobulins that  bind  the  same 
antigen. Antiidiotypic sera have been used to perturb T  cell function both in 
vivo and  in  vitro  (7,  11,  13,  14)  and are capable  of binding antigen-specific 
factors secreted by T  cells (4,  5,  9).  Furthermore, in a  number of systems, the 
expression of idiotypic determinants by T  cells is linked to the CH locus (9,  15- 
18).  As  summarized previously (19),  two  conclusions often have been  drawn 
from experiments demonstrating idiotype expression by T  lymphocytes. First, it 
has been proposed that T  cells transcribe VH gene segments joined not to the 
immunoglobulin D, Jm and CH gene segments, but to  T  cell-specific constant 
region gene segments. Second, it has been hypothesized that T and B cells utilize 
the VH  gene repertoire similarly, such  that  the two types of lymphocyte will 
transcribe identical or closely related VR gene segments in response to the same 
antigen. 
We set out to  determine whether T  and  B  cells that  respond to  the  same 
antigen and share idiotypic determinants do in fact transcribe the same VH gene 
segments.  We  have  chosen  to  analyze  the  murine  immune response  to  the 
synthetic polypeptide, glutamic acid  6°, alanine  s°, and tyrosine  1° (GAT), for two 
reasons. First, the B cell response to GAT displays limited diversity, as evidenced 
by a restricted isoelectric focusing pattern (20), a predominant idiotype, CGAT 
(21), and >90% amino acid sequence identity for the NH~-terminal residues of 
five monoclonal anti-GAT heavy chains (22).  Therefore, it is likely that there 
are, at most, a few highly homologous VR gene segments expressed in the murine 
B cell response to GAT.  In fact, most of the NH2-terminai sequences of heavy 
chains  from  both  GAT  and  GA-binding  immunoglobulins are  quite  similar, 
regardless of the presence of the CGAT idiotype (22).  Second, GAT-specific T 
cells of different functional  classes  have  been  maintained either as  clones or 
hybridomas  (6,  23-26,  and  footnote  2)  z  and  many  display  CGAT  idiotypic 
determinants (6,  25,  26).  Therefore we can address directly whether a  set of 
GAT-specific T-cell clones, some of which express idiotype, transcribe the GAT 
VH gene segment. 
We isolated a cDNA clone encoding the GAT VH from a GAT-specific B cell 
hybridoma. Using the GAT VH probe, we tested RNA from 10 GAT-specific T 
suppressor  hybridomas,  one  GAT-specific helper hybridoma, and  two  GAT- 
specific T  helper cell  lines.  Although six  of these T  cells express the CGAT 
idiotype on secreted, antigen-binding factors, we were unable to detect a GAT 
VH transcript in any of the T  cell RNAs. We therefore conclude that T  and B 
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TABLE  I 
Characteristics of T Cell Clones 
Strain of  T  cell 
T  cell  normal T  cell  Fusion  Type of 
clones  parent  partner  lmmunogen  functional  class  factor* 
CGATidiotype 
Anti-  Mono-- 
sera¢  ctonal ! 
Antigen 
specificity 
GAT  GA  GT 
258C4.4  DBA/I  BW5147  GAT  Suppressor  TsFi  +  + 
342B1,11  BI0,S  BW5147  GAT  Suppressor  TsFI  +  + 
365C6.4  B10.S  BW5147  GAT  Suppressor  TsFx 
367A5,2  CBA  BW5147  GT  Suppressor  TsFi 
368B1.5  BALB/c  BW5147  GT  Suppressor  TsFi  +/- 
Fc30t D4.5  BI0,M  BW5147  GT  Suppressor  TsFi 
Fc301A2.3  BI0.M  BW5147  GT  Suppressor  TsFl 
469B5.5  BI O,A  BW5147  GT and TsFz  Suppressor  TsF2  + 
372B3.5  BI0  BW5147  GAT-M¢I  Suppressor  TsFi  +  +/- 
372D6.5  BI0  BW5147  GAT-M¢  I  Suppressor  "l'sF~  + 
145F3511  BI0.A  BW5147  GAT  Helper** 
BB02'  C57BL/10  None  GAT  Hetpel  x* 
BD01'  (BI0 X B10.D2)FI  None  GAT  Helper  I:1: 
-t-  - 
-  + 
+ 
-  + 
+ 
+ 
-  + 
-  + 
-  + 
*  The Ts hybridomas  secrete  either TsFh an antigen-binding  suppressive  factor composed  of a  single polypeptide  chain, or TsF~,  a  factor 
containing  two chains, one of which binds antigen. 
*  Guinea pig antisera raised against mouse GAT-binding antibodies that had been purified on antigen-affinity columns (5). 
I  Monoclonal  antibody to GAT idiotypic determinants (j. Theze, manuscript in preparation). 
I  Injected as neonates with GAT coupled to macrophages. 
** Cells synthesize IL-2 in response to antigen and syngeneic antigen presenting cells. 
~t Cells proliferate  and synthesize  IL-2 in the presence  +of GAT and syngeneic  macrophages  and provide  help to normal  B  cells for GAT- 
specific plaque forming cell responses in vitro. 
cells responding  to the same antigen  do not  use the same Vn gene segment.  In 
keeping  with  this  result,  the  data  demonstrating  the  expression  of  idiotypic 
determinants  on T  cells may need to be reinterpreted. 
Materials  and  Methods 
B and T Cells.  The GAT-specific  B  cell  hybridoma, F9-238.9,  was produced by the 
fusion of GAT-primed DBA/2 spleen cells and the HAT-sensitive myeloma cell line, P3- 
X63-Ag8  (27).  The resulting hybridoma synthesizes both the MOPC21  (~q, ~) immuno- 
globulin derived  from the myeloma parent and a  GAT-binding  immunoglobulin (u,  r) 
(Fig.  1).  The  F9-238.9  cells  were  derived  by  Dr.  Michel  Pierres  (INSERM-CNRS, 
Marseille) and kindly provided by Dr. Ronald N. Germain (National Institutes of Health, 
Bethesda, MD). 
The suppressor T cell hybridomas were derived from splenic T cells of mice immunized 
either with GAT, GT, TsF plus GT, or neonatally with GAT conjugated to macrophages. 
In each case,  the  cells were fused to BW5147,  a  HAT-sensitive  T  lymphoma of AKR 
origin  (23-25).  A  GAT-specific  T  helper  cell  was  cloned  by  culturing  nylon  wool 
nonadherent lymph node cells from GAT-primed  B10.A  mice on irradiated syngeneic 
spleen cells and GAT.  The  resulting T  cell blasts were fused to BW5147.  The hybrids 
were assayed for IL-2 production in the presence of GAT and syngeneic spleen cells and 
cloned  by  limiting  dilution  (28).  Furthermore,  T  helper  cell  lines  were  derived  from 
lymph  node  lymphocytes of mice  primed  in  vivo with  soluble  GAT  according  to  the 
techniques described by Kimoto and Fathman (29). They were maintained in culture with 
GAT  plus  supernatant  from  Con  A-stimulated  rat  spleen  cells  without  filler  cells  as 
described?  Since T  cell hybridomas and clones are genetically  unstable,  the cells were 
expanded  in  liquid  culture  from frozen stocks and assayed  for GAT-specific  reactivity 
before RNA isolation (23-25,  28, 30, and footnote 2). In all cases, the cells were harvested 
and the resulting pellets frozen at -70°C.  The characteristics of the T  cell hybrids and 
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clones that we analyzed are summarized in Table I. 
RNA Isolation.  The frozen cell pellets were lysed by vortexing in 4  M guanidinium 
thiocyanate (Tridom,  Hauppage,  NY),  25  mM  sodium  acetate,  pH  5,  0.5%  sodium 
sarkosyl, 0.33% antifoam (Sigma Chemical Co., St. Louis, MO), 1 M/3-mercaptoethanol. 
The RNA was purified by centrifugation through a cushion of cesium chloride (31), and 
the poly(A)-containing fraction enriched by sequential passages  over oligo(dT) cellulose 
(32)  (Type  3,  Collaborative  Research,  Waltham,  MA).  The  RNA  concentration was 
determined spectrophotometrically. 
Construction of cDNA Library.  A cDNA library was constructed using  15 t~g poly(A)- 
RNA from F9-238.9 GAT-specific B cells.  Synthesis of the first cDNA strand by AMV 
reverse transcriptase (Life Sciences, Inc., St. Petersburg, FL) was carried out with minor 
modifications of published procedures (33-36).  The synthesis was  initiated at random 
sites along the mRNA  by the addition of sheared calf thymus DNA primer (37).  The 
primer was prepared by digesting calf thymus DNA with DNase I to an average size of 
10-15  nucleotides. RNasin (Biotec, Madison, WI) was added to the reverse transcriptase 
reaction to inhibit degradation of the RNA template (38). 
The alkaline hydrolysis of the  RNA and subsequent synthesis of the second cDNA 
strand by Escherichia coli DNA polymerase I (Boehringer Mannheim Biochemicals, Indi- 
anapolis, IN) were performed as previously described (33, 34, 39). Following digestion of 
the single-stranded loop with Aspergillus S1 nuclease (Sigma Chemical Co.) (33, 34), the 
double-stranded cDNA  was  fractionated by gel  filtration on  a  Biogel A150  (Bio-Rad 
Laboratories, Richmond,CA) column. The cDNA greater than 500 nucleotides in length, 
with an average size of "~ 800 bases, was tailed at each 3' end with 10-15 dCTP nucleotides 
using terminal deoxynucleotidyl transferase (New England Nuclear, Boston, MA) (40). 
The cDNA was then annealed to the tetracycline-resistant plasmid, pBR322, which had 
been digested with the restriction enzyme PstI (New England Biolabs,  Beverly, MA) and 
tailed at the resulting 3' ends with 8-10 nucleotides of dGTP. The annealed DNA was 
used  to  transform  E.  coli strain  MC1061  (41),  as  described  (42)  and  the  resulting 
transformants were selected by plating on nitrocellulose filters (Millipore, Bedford, MA) 
placed  on  media  containing  15  gg/ml  tetracycline.  Replica  filters were prepared  for 
hybridization or frozen for storage as described (43). 
Isolation of pGAT50,  the GAT VH cDNA Clone.  The cDNA library was screened with a 
mixture of 32 pentadecamers 
A 
,  A  T  A  T  , 
(5 CATGTAGGTGTCcTT3 ), 
C 
which are complementary to the mRNA predicted to encode residues 30-34 of the GAT 
immunoglobulin heavy chain.  The oligonucleotides were synthesized at Hoffmann-La- 
Roche (Nutley, NJ) and kindly provided by Dr. Kenneth Wieder (formerly at Hoffman- 
LaRoche, currently at DuPont Co., Wilmington, DE). The probe mixture was labeled at 
the 5' end with T4 polynucleotide kinase and [3,-~ZP]dATP (ICN, Irvine, CA) (44). Before 
screening with  the  radioactive probe,  plasmid  DNA was  amplified for 36  h  on plates 
containing 12.5 ~g/ml chloramphenicol. The bacterial cells then were lysed and prepared 
for hybridization with the probe as described (43). Duplicate filters were prehybridized at 
23°C for 3 h  in hybridization buffer, consisting of 5X SET (0.75  M sodium chloride/ 
0.15 M Tris, pH 8/5 mM ethylendiaminetetraacetic acid), 5X Denhardt's solution (45), 
10 #g/ml each of poly(rA), poly(rC), and poly(rG), 0.5% sodium dodecyl sulfate, and 250 
ug/ml denatured,  sheared salmon sperm DNA.  The probe was added to the filters in 
fresh  hybridization buffer at  0.5  pmol/ml  or  5.5  x  106  cpm/ml.  Following  16  h  of 
hybridization at 23°C, the filters were washed in 5 X SET, 0.1% sodium dodecyl sulfate, 
0.1% sodium pyrophosphate at 23 °C and exposed to Kodak XAR-5 film with an intensi- 
fying screen at -80°C. 
DNA Sequencing.  DNA digested with restriction endonucleases (New England Biolabs, 
Inc.,  Beverly, MA),  was  subcloned into the  bacteriophage vector, M13mp8  (Bethesda 196  THE  GAT  T  CELL  RECEPTOR  IS  NOT  GAT  VH 
Research Laboratories, Gaithersburg, MD) and sequenced by the dideoxy method (46). 
Alternatively, DNA fragments labeled at the 5' ends with T4 polynucleotide kinase were 
digested internally with a  second restriction endonuclease and  the  labeled fragments 
purified and sequenced by the Maxam-Gilbert technique (47). 
Northern  Blots.  Poly(A)-containingRNA was  denatured, electrophoresed in  agarose 
gels containing formaldehyde (48) and blotted to nitrocellulose (49). E. coli 16S and 23S 
rRNAs and murine  18S and 28S  rRNAs were electrophoresed in parallel as molecular 
weight standards. The filters were hybridized at 42 °C in formamide and dextran sulphate 
(Pharmacia Fine Chemicals, Piscataway, N  J) as previously described (49), with the addition 
of 5 ug/ml liver poly(A)-minus RNA. The blots were washed in 0.3 M sodium chloride, 
0.03 M sodium citrate, and 0.1% sodium dodecyl sulfate, pH 7, at 50°C and then exposed 
to Kodak XAR-5 film using an intensifying screen. 
Hybridization Probes.  The following cloned DNAs were labeled to a specific activity of 
2-8 ×  108 cpm/#g by nick-translation (50). (a) C,  probe. Plasmid pSp~A 1 (51) was digested 
with four restriction endonucleases, BamHI, KpnI, EcoRI and XbaI  to produce a  2.5-kb 
fragment containing the exons encoding C~3, Ctz4 and half of C#2. This DNA fragment 
was purified from a preparative agarose gel by electroelution (52). (b) MOPC21 probe. A 
cDNA containing virtually the entire  MOPC21  heavy chain variable region gene was 
cloned into pBR322 (53). (c) V11 probe. A 3.5-kb SauIIIA restriction fragment, containing 
the genomic V11  gene segment (54),  was subcloned into pBR322. V11  is a member of 
the TEPC 15 gene family. DNA was kindly provided by Dr. Johanna A. Griffin (University 
of Alabama, Birmingham, AL). (d)  V14A  probe. A  BamHI-EcoRI restriction fragment 
containing most of the genomic VH gene segment, V14A, was subcloned into pBR322 
(Stephen Crews, unpublished observation). The translation of the V 14 DNA sequence is 
very similar to the protein sequence of the J606 myeloma heavy chain. The DNA was 
given to us by Dr. Stephen Crews (California Institute of Technology, Pasadena, CA). (e) 
S107 probe.  A  cDNA  clone  containing the  VH  gene segment expressed  by the  S107 
myeloma was previously isolated (2). S107 is a member of the TEPC15 gene family. The 
DNA was prepared by Dr. J. A. Griffin. (f) GAT50 probe. The derivation of the GAT VH 
cDNA clone, pGAT50, is described in this manuscript. (g) H-2 class I probe, pH2-IIa was 
subcloned from a cDNA encoding a class I gene of the d haplotype (55). The DNA was 
provided by Dr.  Michael  Steinmetz (Basel  Institute, Switzerland). (h)JH probe. A  2-kb 
fragment containing all four JH gene segments was excised from a plasmid subclone of 
the lambda clone #27 (51), as described elsewhere (53). 
Results 
Isolation  of pGAT50,  a GAT Vn cDNA Clone.  To isolate a cDNA clone contain- 
ing  the  GAT  immunoglobulin  VH  coding  region,  we  had  to  overcome  two 
technical problems.  First,  the #  RNA  is  long,  ~2.4  kb  in  length and  the  VH 
region is located at its 5' end. Conventionally, cDNA synthesis is initiated by an 
oligo(dT)  primer  hybridized to  the  poly(A)  tail  found at  the  3'  end  of most 
eucaryotic messenger RNAs. Therefore, to obtain a clone containing the entire 
GAT VH would require synthesis of a cDNA >2 kb in length. Since cDNAs this 
long are rare, we initiated synthesis using short fragments of calf thymus DNA 
as a  primer.  This primer could anneal at various points along the mRNA and 
the cDNA synthesized would derive from the 5' end of the RNA more frequently 
than with an oligo(dT) primer. Therefore, the probability of cloning the entire 
VH coding sequence would be increased. 
The second technical problem arose because the B cell hybridoma producing 
anti-GAT antibody, F9-238.9, contains "-~ 10 times more ~1 heavy chain mRNA 
derived  from  the  P3-X63-Ag8  myeloma  parent  than  #  heavy  chain  mRNA 
containing the GAT VH. This is demonstrated by hybridizing a  blot containing KRAIG  ET  AL.  197 
the B cell RNA with a  germline Jn probe capable of detecting all heavy chain 
messenger RNAs (Fig. 1). Hybridization to the 1.9-kb MOPC21 7 mRNA species 
is significantly more intense than hybridization to the 2.4-kb #  RNA encoding 
the GAT heavy chain. In addition, the F9-238.9 cells secrete approximately one- 
tenth as much # as 3' heavy chain (Kraig, data not shown). To distinguish between 
the clones containing the GAT VH and the more prevalent clones encoding the 
MOPC21  Vn, initially we screened the cDNA library with a C, probe. Although 
several clones containing portions of the VH sequence were isolated, no cDNA 
clones  containing  the  entire  GAT  VH  gene  were  identified.  Since  the  NH2- 
terminal amino acid sequence of several GAT-binding immunoglobulin heavy 
chains had been determined (22), it was possible to synthesize an oligonucleotide 
probe,  complementary to  the  RNA sequence predicted to encode amino acid 
residues 30-34 (Fig. 2).  Because there exist ambiguous positions in the reverse 
translation from amino acid into nucleotide sequence, the complements of all 32 
possible coding sequences were synthesized. We hybridized the pool of labeled 
pentadecamers to the cDNA library under conditions which would distinguish 
between MOPC21  VH, which has no more than 12 of 15 nucleotides identical to 
any of the  32  pentadecamers, and the GAT VH,  which should be identical to 
one of the probes  at  all  15  positions.  Of 6,000  cDNA  clones screened, one, 
designated pGAT50,  hybridized to the pool of radioactive pentadecamers and 
was characterized further. 
The nucleotide sequence of pGAT50  and the sequencing strategy used are 
FIGURE  1.  Hybridization of a  probe containing the four J. gene  segments to a  Northern 
blot of poly(A)-RNA from the F9-238.9 GAT B cell hybridoma. The migration distances of 
the RNA molecular weight standards and their sizes in kilobases are indicated. The positions 
of the bands containing MOPC21-3,1  RNA and GAT VH-~t RNA are shown. 198  THE  GAT  T  CELL  RECEPTOR  IS  NOT  GAT  VH 
Position  30  31  32  33  34 
Amino  acid  K  D  T  Y  M 
A 
mRNA sequence  5'  AA~  CA U  ACcG  UA  U  AUG  5' 
T 
T 
OLigonucleotides  .3'  TT T  CT~  TG C  AT A  TAC  5' 
A 
FIGURE 2.  Oligonucleotide probes  for the OAT VH sequence.  The  OAT VH amino acid 
sequence, the predicted mRNA sequences and the pentadecamers used in this study as probes 
complementary to the mRNA are shown. 
!  TTCTGGTAGTTCCANGTGAAGGAAATGGTGCTGGGCAGGAPGTCCCGGGCCAPGCAGCCC  60 
-19  IN  K  C  S  -16 
61  ATGAGCCCTATCTTCTCTACAGACACTGAATCTCAAGGTCCTTACAATGAAA  TGCAGC  1~8 
-t5  W  V  I  F  F  L  M  A  V  V  T  G  V  N  S  [ E  V  (]  L  G  5 
1~9  TGGGTTATCTTCTTCCTGATGGCAGTGGTTACAGGGGTCAATTCAGAGGTTCAGCTGCAG  178 
6  O  S  G  A  E  L  V  K  P  G  A  S  V  K  L  S  C  T  A  S  25 
~79  CAGTCTGGGGCAGAGCTTGTGAAGCCAGGGGCCTCAGTCAAGTTGTCCTGCACAGCTTCT  238 
26  G  F  N  I  K  D  T  Y  M  H  W  V  K  Q  R  P  E  g  G  L  45 
239  GGCTTCAACATTAAAGACACCTATATGCACTGGGTGAAGCAGAGGCCTGAACAGGGCCTG  298 
46  E  W  I  G  R  I  O  P  A  N  G  N  T  K  Y  O  P  K  F  Q  65 
299  GAGTGGATTGGAAGGATTGATCCTGCGAATGGTAATACTAAATATGACCCGAAGTTCCAG  358 
66  G  K  A  T  I  T  A  O  T  S  S  N  T  A  Y  L  g  L  S  S  85 
359  GGCAAGGCCACTATAACAGCAGACACATCCTCCAACACAGCCTACCTGCAGCTCAGCAGC  418 
e6  L  T  S  E  D  T  A  V  Y  Y  C  A  S  J V  V  G  S  S  Y  I  Y  105 
4t9  CTGACATCTGAGGACACTGCCGTCTATT  ATTGTGCTAGTTACT  ACGGTAGTAGCTACTAC  47B 
106  Y  W  G  Q  G  T  T  L  T  V  S  S  I  E  5  Q  S  F  P  N  V  ~25 
479  TACTGGGGCCAAGGCACCACTCTCACAGTCTCCTCAGAGAGTCAGTCCTTCCCAAATGTC  538 
126  F  P  L  V  S  C  E  S  P  L  S  O  K  N  L  V  140 
539  TTCCCCCTCGTCTCCTGCGAGAGCCCCCTGTCTGATAAGAATCTGGT  585 
5'UT  L  V  ,D,J.2  C~ 
mRNA  ....  '  '  --- 
GAT50  cDNA  ~  ~  +  •  ?ob~ 
M 13 subctones  i  • 
Fragments  for 
Maxam-Gilber t  ,,  ,  * 
sequencing 
FIGURE 3.  Characterization  of pGAT50.  The  pGAT50  eDNA  clone  is  shown  with  the 
recognition sites for the restriction endonucleases, Pst I (~),  PvulI (~), and StuI (1  =) indicated. 
The specified restriction fragments from pGAT50 and pGAT40 (.), a second eDNA clone 
containing only part of the GAT VH sequence, were subcloned into M 13mp8, a bacteriophage 
vector, and sequenced in the direction indicated by the arrows by the dideoxy method (46). 
The sequence of pGAT50 was confirmed and extended by the Maxam-Gilbert method (47) 
from the StuI site, as shown. The resulting DNA sequence of pGAT50 and its tranlation into 
protein sequence are given. The position of the pentadecamer used as probe is underscored. 
Vertical lines delineate the 5' UT, L, Vm D, andJu portions. KRAIG  ET  AL.  199 
summarized in  Fig.  3.  The cDNA clone contains  106  nucleotides from the 5' 
untranslated (UT)  region, a  sequence capable  of encoding a  hydrophobic  19 
amino acid leader (L) peptide, complete Vn,  D, and JH gene segments and 72 
nucleotides of the C~ gene. The VH, D, and JH gene segments have rearranged 
in  a  continuous translational  reading frame, indicating that  the  cDNA  clone 
encodes  a  functional  V  region  coding  sequence.  The  amino  acid  sequence 
predicted from pGAT50 (Fig. 3) agrees with the 33 residues of published NH2- 
terminal protein  sequence data  for the  F9-238.9  heavy chain (22).  The  D  is 
identical to DrL16.~ (56) and theJ gene segment used isJ.2 (57). The clone also 
contains 72 nucleotides whose translated sequence is identical to that published 
for the most NH2-terminal portion of the first domain of the C~ region (58). 
GA T-spec~c T Cells Do Not Transcribe the GAT VH Sequence.  RNA was extracted 
from 11 different GAT-specific T  cell hybridomas and two T  cell lines (Table I) 
and the poly(A)-containing RNA purified by two or three sequential passages 
over oligo(dT)-cellulose. 10 #g of each T  cell hybridoma RNA were separated 
by size on a  denaturing gel, blotted to nitrocellulose, and hybridized with the 
radioactive pGAT50  probe.  Each  RNA  was examined on  three  independent 
Northern  blot  hybridizations,  yet  there  was  no  evidence of a  T  cell  mRNA 
species that hybridized to the GAT V, probe (a characteristic blot is shown in 
Fig. 4).  Similarly, there was no GAT VH sequence in  3-6 #g of poly(A) RNA 
from two TH lines, BB02' and BD01' (data not shown). The GAT VH sequence 
could, however, be detected when as little as 50 ng of poly(A)-containing RNA 
from the B cell hybridoma was loaded on the gel (Fig. 4). 
The T  cell RNA was shown to be present and undegraded by a positive control 
hybridization using pH2-IIa, a cDNA clone encoding an H-2  a class I polypeptide 
(Fig.  5).  All of the T  cell RNAs contained an mRNA  "~ 1.9  kb in  length that 
hybridized to the H-2 probe and encodes the H-2 class I polypeptide localized in 
the cell membrane. In addition, several of the Ts hybridoma RNAs had a second 
mRNA of "--1.8  kb that hybridized to the class I probe. This smaller species of 
mRNA had been observed previously in liver and possibly encodes a secreted H- 
2 class I polypeptide (59). 
If the T cell RNA contained a transcript from a gene related, but not identical, 
to the GAT VH gene, the hybridization signal would be less intense than expected 
for identical sequences. To determine the degree to which nucleotide sequence 
divergence would affect the hybridization signal, several VH gene probes were 
hybridized to 2 ng of purified heavy chain RNA from the myeloma S107. For a 
particular messenger RNA present at 50 copies per cell, 2 ng would approximate 
the amount of that RNA present in  10 #g poly(A)-RNA. All hybridizations were 
done using conditions identical to those described for the analysis of GAT Vrt 
expression by T  cells. The Northern blots are shown in Fig. 6. Hybridization of 
the S107 RNA to the VH11 probe, which shares 90% sequence identity, showed 
a  three- to  fivefold loss  of signal when compared with hybridization with  the 
completely identical S 107 probe. Furthermore, the V 14A probe, which shared 
only 75% sequence similarity with the S107 RNA, gave no detectable signal. So, 
if the T  cell hybridomas or cell lines contained a  Vr~ sequence, sharing <80% 
sequence similarity with the GAT VH probe,  this transcript would most likely 
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FIGURE 4.  Hybridization of a Northern blot containing RNA from GAT-specific T  and B 
cells with the pGAT50 probe. Varying amounts of poly(A)-RNA from F9-238.9,  the GAT-B 
hybridoma, were loaded as follows: 500 ng (lane 1), 200 ng (lane 2) and 50 ng (lane 3).  10 ttg 
of poly(A) T  cell RNA from BW5147 (lane  10) and the T  cell hybridomas were loaded  as 
follows: lane  4,  Fc301D4.5; lane  5,  342B1.11;  lane  6,  365C6.4;  lane  7,  258C4.4;  lane  8, 
367A5.2; lane 9, 368B1.5;  lane  11,  145F3511;  lane  12, Fc301A2.3; lane  13, 469B5.5;  lane 
14,  372B3.5;  and  lane  15,  372D6.5.  The  spot  in  the  center  of the  autoradiogram  is  a 
background artifact.  It does not correlate with a lane and was not observed in other Northern 
blots of these RNAs. The positions and sizes (in kilobases) of the rRNA markers are indicated. 
Discussion 
We wished  to determine  whether  T  and  B  cell  receptors  that  bind  the  same 
antigen  and  share  idiotypic  determinants  are  encoded  by similar  VH  gene  seg- 
ments.  Since GAT-specific T  cells have been cloned and since the murine  B  cell 
response  to GAT  is  restricted  in  diversity we have looked for Vr~ expression  in 
GAT  T  cells.  To do so, we obtained and characterized a  cDNA clone (pGAT50) 
containing the  entire  Vn coding squence from  F9-238.9,  a  GAT-specific B  cell 
hybridoma. The  cDNA clone has been sequenced and is identical to the mRNA 
predicted  from  the  34  NHz-terminal  amino  acid  residues  determined  for  the 
GAT-binding  antibodies  (22).  Since  the  B  cell  response  to  GAT  is  relatively KRAIG ET  AL.  201 
FIGURE 5.  Hybridization of a Northern blot of T cell RNAs with an H-2 class I probe. The 
blot used in Fig. 4 was rehybridized with  pH2-IIa, a murine class I probe. Residual  hybridization 
of pGAT50 to the B cell RNA is observed. The positions  and sizes (in kilobases) of the rRNA 
markers are indicated. 
homogeneous, pGAT50  certainly should hybridize to mRNA encoding any of 
the five sequenced heavy chains present in antibodies which bind GAT. There- 
fore, if B and T  cells responding to the same antigen use the VH gene repertoire 
in a similar way, we would expect the GAT Vn probe to hybridize to transcripts 
from the GAT-specific T  cell hybridomas or clones. 
In addition, six of the suppressor T  cell hybridomas secreted factors that had 
determinants detected by a  heterologous anti-CGAT idiotype serum.  Of these, 
three  were  also  positive  with  a  monoclonal  antiidiotypic  reagent  (J.  Kapp, 
unpublished  observations).  The  two  T  cell  lines,  although  they  showed  no 
reactivity with  the  monoclonal antibody,  might have  CGAT  determinants de- 
tectable with the heterologous anti-CGAT serum, since similar clones that have 
been tested were positive (6).  The remaining T  cell hybridomas have not been 
examined for CGAT idiotype expression. Using pGAT50 as a probe, no hybrid- 
izing RNA species were detected on Northern blots of 13 different T  cell RNAs. 202  THE  GAT  T  CELL  RECEPTOR  IS  NOT  GAT  VH 
FIGURE 6.  Hybridization of S107  heavy chain-encoding RNA with  VH probes of varying 
sequence similarity. 2 ng of sucrose gradient purified S 107 heavy chain RNA was hybridized 
with the S107 probe, 100% identical (lane I), the VH11  probe, 90% sequence similarity,  (lane 
2), and the VH 14A probe, 75% sequence similarity (lane 3). 
The  GAT-specific  T  cell  hybridomas  represented  three  different  functional 
classes, Tsl 1,  Ts21,  and  TH;  the  two  T  cell lines have  TH  function. 2 To  ensure 
that  the  cells  tested  had  maintained  antigen-specific  function,  all  lines  were 
assayed for GAT-specific reactivity after expansion  in  culture and  before  RNA 
purification. Positive control hybridizations with an H-2 class I  probe argue that 
the RNA  was intact and capable of hybridizing to complementary  DNA  probes. 
Although  the  GAT  heavy chain  transcript is only moderately  abundant  (Fig. 
1), the GAT  VH sequence was detected in as little as 50 ng of poly(A)-RNA from 
the B  cell hybridoma  producing  anti-GAT  antibody.  Since  10 ~g of each T  cell 
hybridoma  poly(A)-RNA was tested, we conclude that there must be at least 200 
times (10 #g/50  ng) less GAT  VH-encoding RNA  in the T  cell hybridomas than 
in  the  B  cell  hybridoma.  We  estimate  the  detection  limit of this  analysis to  be 
1.5  copies  of GAT  VH  sequence  per  T  cell  for  the  hybridomas. 4  A  similar 
calculation yields an estimated detection limit of 5-10  copies per cell for the  3- 
4 By comparing the signal obtained with JH, MOPC21  VH, GAT50 Vm and C~ probes hybridized 
to F9-238.9 RNA and purified myeloma RNAs, we estimate that ~0.2% of the F9-238.9 poly(A)- 
RNA encodes the GAT Ig heavy chain (Kraig and Kronenberg, unpublished observation). The 5' 
untranslated (5' UT) region plus VH comprise 21% = (500/2,400) of the mass of the entire # mRNA. 
Therefore, the Vn plus 5' UT should be present at 0.04% of the mass of the F9-238.9 poly(A) RNA. 
A sequence this abundant could be detected in 50 ng of B cell RNA (Fig. 4, lane 3), so in the 10 #g 
of each T  hybridoma poly(A) RNA tested, we could have detected an homologous Vn  sequence 
present in T  cells at 0.00021%  of the mass of the poly(A) RNA. Assuming 0.2 pg poly(A)RNA per 
T  cell (53),  we could have detected as little as 4  x  10  -7 pg VH/cell. One molecule of 5" UT-VH 
weighs  2.76  ×  10  -7 pg =  (500  nucleotides) (330  daltons/nucleotide) (1.67  x  10  -12 pg/dalton). 
Therefore the calculated detection limit is 1.5 molecules/cell =  (4 ×  10  -v pg detectable/cell)/(2.76 
×  10  -7 pg/5'  UT-Vn).  This number  is a  best estimate, but  there  is a  degree of uncertainty in 
determining both the percentage of the F9-238.9 poly(A)-RNA that encodes the GAT immunoglob- 
ulin heavy chain and the amount of poly(A)-RNA per cell in the T-cell clones. Since less RNA from 
the Tn  cell lines  was  tested,  the detection limit is two-  to  threefold higher  than  for  the T  cell 
hybridomas. KRAIG ET  AL.  203 
6 #g of RNA from the two T  cell lines tested. With the sensitivity of the Northern 
blots,  we  easily  could  have  identified  transcripts  as  abundant  as  the  mRNA 
encoding ~ heavy chain in B lymphomas, -~ 100 copies per cell (60). Furthermore, 
most mRNAs in the low abundance class are present in mammalian  cells at 5- 
20 copies per cell (61), so we could have detected even a transcript  in this class. 
Nevertheless, the T  cells analyzed do not contain detectable levels of a messenger 
RNA similar to GAT Vn. This result is consistent with a report that a  Ts clone 
that  secretes a  TsF  that  binds phosphorylcholine  and  shares  the  predominant 
idiotype (TEPC 15) of PC-binding antibodies, fails to transcribe or rearrange the 
TEPC15  VH gene segment (62).  Therefore,  we conclude that  shared  idiotypic 
determinants need not imply transcription  of similar VH genes. 
There  are  two limitations  to the analysis we have presented.  First,  although 
unlikely, the homologous RNA could be present, with an average abundance of 
<1.5  molecules  per  cell.  For  example,  despite  the  fact  that  antigen-specific 
function  was assayed,  it  is  possible that  only  10%  of the  T  lymphocytes were 
synthesizing antigen-receptor  mRNA at the  time  of harvest.  We consider  this 
improbable,  since function was tested after the cells were expanded in culture 
and 10 different suppressor hybrids were analyzed. Furthermore,  for the helper 
T  hybridoma,  the  amount  of  IL-2  released  per  cell  was  unchanged  during 
expansion, so receptor-negative variants had not emerged as a dominant popu- 
lation. However, if for example, the half-life of the TsF protein were sufficiently 
long,  mRNA  need  not  have  been  continually  present.  Second,  the  degree  of 
hybridization  detected on a  Northern  blot is greatly affected by the amount of 
sequence similarity  shared between the probe and the  RNA tested. Thus,  if a 
GAT-specific T  cell contained a VH gene segment that shared only 80% sequence 
similarity  with  pGAT50,  this  T  cell  transcript  probably would not  have  been 
detected. However, in the accompanying manuscript (53), we report the screen- 
ing  of T  cell  cDNA  libraries  directly  with  probes  capable  of hybridizing  to 
virtually any known  VH sequence. These experiments demonstrate  that  T  cells 
probably do not transcribe any gene segments from the B cell V~ repertoire. 
Since there is no evidence for transcription  of similar VH gene segments by T 
and B cells responding to the same antigen, how does one explain the occurrence 
of shared idiotypic determinants on some of these cells? First, it should be noted 
that serological cross-reactivity between molecules does not imply that they share 
extensive similarities  in primary structure.  In fact, there are numerous cases in 
which either  complex antisera  or monoclonal reagents detected cross-reactions 
between molecules lacking extensive sequence similarity (63-66).  For example, 
antiidiotypic  antibodies  raised  against  antibodies  to  insulin  interfere  with  the 
binding of insulin to its receptor (65). 
Generally there are two ways to consider the expression of idiotypic determi- 
nants  by  T  lymphocytes.  The  cross-reactivities  observed  may  be  biologically 
irrelevant.  For example,  in  some cases,  it is possible that T  and  B cell antigen 
receptors reported to share idiotypic determinants actually express no common 
serological specificity. If the immunogen  used to raise the antiidiotypic reagent 
contained contaminating T  cells or T  cell-derived antigen-binding  material,  the 
resulting  sera  would detect  different  determinants  on  both  B  and  T  cells.  In 
other cases, detection of idiotype expression by T  lymphocytes depended on the 204  THE  GAT  T  CELL  RECEPTOR  IS  NOT  GAT  VH 
use of complex antisera, containing multiple serological specificities. In such a 
complex sera, a  minor subset of antibodies might recognize a  determinant on 
both B and T cell receptors, although these molecules share little or no structural 
similarity. Since the assay for T  cell idiotype is often the ability to disrupt T  cell 
activity  in  vitro,  perturbations  in  T  cell  function  due  to  a  minor  subset  of 
antibodies  would  not  be  easily  distinguishable  from  inhibition  by  the  major 
components of the antiidiotypic sera. No doubt other explanations are possible 
and no single rationale can account for every report of idiotype expression by T 
cells. 
However, the sharing of idiotypic determinants by B and T cells may be instead 
a biologically relevant phenomenon. It may either reflect a selection mechanism, 
like networks (67), proposed to act similarly on B and T  cell antigen receptors, 
or may be due to constraints on antigen recognition itself. We feel the data are 
most consistent with a common regulatory mechanism for several reasons. First, 
it has been demonstrated that monoclonal antiidiotypic reagents can react with 
T  lymphocytes, so in  these cases,  the reactivity probably is not due to  minor 
components in a complex sera (10, 68; J. Kapp, unpublished observation). These 
data demonstrate that T and B lymphocytes probably can share a single serologic 
determinant.  However,  even  monoclonal  antibodies  may  recognize  multiple 
specificities. Second, the presence of idiotypic determinants on T  lymphocytes 
generally is correlated with antigen specificity. Third, in a number of cases, the 
expression of idiotype by T  lymphocytes is linked to the genes encoding immu- 
noglobulin heavy chain allotypes (9,  15-18).  It has been suggested that the T 
cell receptor for antigen also is encoded on chromosome 12. Alternatively, if the 
putative regulatory mechanism were dominated by B cell antigen receptors, the 
genes encoding the T  cell antigen receptor would appear to map to chromosome 
12 even though they are actually located elsewhere (10). 
Although it is not certain how the presumptive selection mechanism operates, 
it is clear that such selective pressures do exist at least for the B cell compartment. 
For example, mice responding to anti-p-azophenylarsonate primarily synthesize 
antibodies bearing a  cross-reactive idiotype (CRI).  However, if suppressed for 
CRI  production,  the mice nevertheless can generate a  good idiotype-negative 
antibody  response  (69).  Therefore,  for  B  lymphocytes, the  heterogeneity of 
receptors expressed in response to some antigens reflects both the diversity of 
the receptor repertoire and the selective forces that operate on it. Since T  cells 
involved in many immune responses also express determinants, it is possible that 
some  antiidiotypic  sera  recognize  determinants  involved  in  the  selection  or 
regulation of receptors. 
We conclude that T  cells and B cells that recognize the same antigen and share 
idiotypic determinants, need not transcribe similar VH gene segments. Under- 
standing the structural and genetic bases for idiotype expression by T  cells awaits 
a thorough characterization of the antigen-binding molecules themselves and the 
genes which encode them. 
Summary 
We have attempted to determine whether T  cells and B cells that have the 
same antigenic specificity and whose receptors share idiotypic determinants in KRAIG  ET  AL.  205 
fact  express  similar  VH  gene  segments.  To  do  this,  we  have  obtained  and 
characterized a  cDNA clone containing the entire coding sequence for the VH 
gene from a  glutamic acid6°/alanineS°/tyrosine  1° (GAT)-binding immunoglob- 
ulin  that  carries  the  CGAT  idiotype.The  GAT-Vn  clone  was  hybridized  to 
Northern blots of GAT-specific T  cell RNAs; there was no evidence of a  T  cell 
transcript that hybridized to the GAT-VH probe. The T  cells analyzed included: 
(a)  10 GAT-binding suppressor T  cell hybridomas, 6  of which secreted factors 
with CGAT  idiotypic determinants, (b)  one  GAT-specific helper T  cell hybri- 
doma,  and  (c)  two  GAT-specific  helper  T  cell  lines  grown  in  the  absence  of 
feeder cells. The detection limit of the Northern blot analysis was 1-2 copies of 
a particular mRNA species per cell for the hybridomas and 5-10 copies per cell 
for the T  cell lines. Therefore, we conclude that T  and B lymphocytes responding 
to GAT do not utilize similar VH gene segments. Furthermore, the presence of 
idiotypic determinants on T  lymphocytes does not necessarily imply close struc- 
tural similarity between T  and B cell antigen receptors. 
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